Fexofenadine

Jump to: navigation, search

Synonyms / Brand Names: Manufactured under the brand name Allegra. It is also known as Terfenadine-COOH, Terfenadine carboxylate, Terfenadine acid metabolite, Fexofenadine hydrochloride, Fexofendine, Carboxyterfenadine.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Seasonal Allergic Rhinitis
Adults and Children 12 Years and Older: The recommended dose of ALLEGRA is 60 mg twice daily, or 180 mg once daily.
Children 6 to 11 Years: The recommended dose of ALLEGRA is 30 mg twice daily.

Chronic Idiopathic Urticaria
Adults and Children 12 Years and Older: The recommended dose of ALLEGRA is 60 mg twice daily.
Children 6 to 11 Years: The recommended dose of ALLEGRA is 30 mg twice daily.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Fexofenadine

Return to top

Publication Resources

Most Recent Articles on Fexofenadine

Review Articles on Fexofenadine

Articles on Fexofenadine in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Fexofenadine

Return to top

Trial Resources

Ongoing Trials with Fexofenadine at Clinical Trials.gov

Trial Results with Fexofenadine

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Fexofenadine

Cochrane Collaboration on Fexofenadine

Cost Effectiveness of Fexofenadine

Return to top

Media Resources

Powerpoint Slides on Fexofenadine

Images of Fexofenadine

Podcasts & MP3s on Fexofenadine

Videos on Fexofenadine

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Fexofenadine

Discussion Groups on Fexofenadine

Patient Handouts on Fexofenadine

Blogs on Fexofenadine

Fexofenadine in the News

Fexofenadine in the Marketplace

Return to top

International Resources

Fexofenadine en Español

Return to top


The content of this page is taken from the FDA package insert for this drug and should not be edited.


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox